Active Ingredient: ZOLPIDEM
(Hérité de ZOLPIDEM ALMUS 10 mg) In human stem cell-derived cardiomyocytes acute zolpidem administration blocks hERG channels and induces cardiac action potential changes that are consistent with clinically observed QT prolongation
https://doi.org/10.1016/j.bpj.2012.11.1661, https://doi.org/10.3389/fpsyt.2022.1033061,